Immutep competitors

View the competitive landscape for Immutep, featuring companies like Novartis, Bristol Myers Squibb, and Merck. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Company icon
Immutep

Biotechnology company developing LAG-3 immunotherapies

immutep.com

List of Immutep competitors

  • Company icon

    Novartis

    Multidivisional healthcare company researching immune checkpoint inhibitors for oncology

    novartis.com
  • Company icon

    Bristol Myers Squibb

    Global pharmaceutical company producing first-to-market LAG-3 checkpoint inhibitors

    bms.com
  • Company icon

    Merck

    Biopharmaceutical company developing pembrolizumab combinations with LAG-3 targeted therapies

    merck.com
  • Company icon

    Incyte

    Biopharmaceutical company developing immunotherapy inhibitors including LAG-3 clinical assets

    incyte.com
  • Company icon

    Regeneron

    Biotechnology company advancing clinical programs for LAG-3 antibody treatments

    regeneron.com
  • Company icon

    MacroGenics

    Clinical-stage biopharmaceutical company developing bispecific antibodies including LAG-3 targets

    macrogenics.com
Track Immutep & Its Competitors

Follow their latest moves with a real-time news feed and summaries delivered straight to your inbox.

More like Immutep & trending lists

Browse competitors related to Immutep and other trending companies.